Telus Peptides

BPC-157

Healing & recovery Research compound (not approved for human use)

Synthetic pentadecapeptide · also known as BPC 157, Body Protection Compound-157

For reference only — not medical advice. Figures are commonly reported values compiled from published sources and may be wrong or out of date. Many compounds listed are not approved for human use. Talk to a licensed clinician before using any compound.

BPC-157 is a synthetic peptide derived from a sequence found in gastric juice. It is one of the most widely discussed research peptides in tissue-repair research and is frequently paired with TB-500 in recovery-oriented protocols.

Commonly reported dosing (5 mg vial)

Reconstituted with 3 mL → 1.667 mg/mL.

Also sold in 10 mg, 20 mg, 40 mg vials.

PhaseDoseVolumeU-100 units
Starting
Weeks 1-2
200 mcg0.12 mL12
Standard
Weeks 3-4
400 mcg0.24 mL24
Higher
Weeks 5-8 and beyond
600 mcg0.36 mL36

Frequency: Once daily, subcutaneous (some reports split it into two injections) · Half-life: Short (minutes to a few hours, route dependent)

Open in calculator

Commonly reported reconstitution steps

  1. Vials are usually brought to room temperature (about 15-20 minutes) first.
  2. 3 mL of bacteriostatic water is added slowly down the inside wall of the 5 mg vial.
  3. The vial is swirled gently until clear, not shaken.
  4. This gives 1.67 mg/mL. Mixed vials are typically labeled with the date and refrigerated.

Storage

Before mixing: Sealed vials are commonly stored refrigerated (2-8 °C) and protected from light, or frozen for long-term storage.

After mixing: Reconstituted solution is commonly kept refrigerated (2-8 °C), protected from light, and not frozen.

Commonly used within 28 days of mixing.

How it works

Research suggests BPC-157 may influence angiogenesis and growth-factor signaling (for example the VEGF pathway), which are associated with tissue repair processes in preclinical models.

Researched for

  • Studied for tendon, ligament, and soft-tissue healing in animal models.
  • Investigated for gastrointestinal protective effects.
  • Commonly combined with TB-500 in recovery research stacks.

Notes

  • Dosing is typically expressed in micrograms, which are small volumes on a U-100 syringe.
  • Human clinical evidence is limited; most data are preclinical, so the amounts shown are community-reported rather than trial-derived.

Sources

Last reviewed 2026-10-06.

Related

TB-500

Thymosin beta-4 fragment

TB-500 is a synthetic version of a region of the naturally occurring protein thymosin beta-4.

5 mg vial · Once daily, subcutaneous (a weekly loading pattern is also reported)

BPC-157 + TB-500 20 mg Blend

Tissue-repair research blend (BPC-157 + TB-500)

This blend combines BPC-157 and TB-500 in a single vial (20 mg by default, with a 10 mg size also listed), a common pairing in recovery-oriented research because the two peptides are studied for complementary roles in tissue-repair research.

20 mg vial · Once daily, subcutaneous

GHK-Cu

Copper-binding tripeptide

GHK-Cu is a naturally occurring copper-binding tripeptide studied for skin, hair, and tissue-remodeling applications.

50 mg vial · Once daily, 5 days per week, subcutaneous (topical formulations are also used)

KPV

Tripeptide fragment of α-MSH

KPV is the three-amino-acid C-terminal sequence of alpha-MSH, studied mainly for anti-inflammatory activity in gut and skin models.

10 mg vial · Once daily, subcutaneous

Tri-Heal 45 mg Blend

Tissue-repair and anti-inflammatory blend (three peptides)

TB-500, BPC-157 and KPV in one 45 mg vial, with TB-500 making up more than half the mass.

45 mg vial · Once daily, subcutaneous

GLOW 70 mg Blend

Tissue-repair and skin-support blend (three peptides)

A three-peptide vial combining copper peptide GHK-Cu with BPC-157 and TB-500, two peptides common in tissue-repair research.

70 mg vial · Once daily, subcutaneous